Business Description
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 51.31 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -15.5 | |||||
3-Year EPS without NRI Growth Rate | -13.6 | |||||
3-Year FCF Growth Rate | -13.7 | |||||
3-Year Book Growth Rate | -19 | |||||
Future 3-5Y EPS without NRI Growth Rate | 58.89 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 62.27 | |||||
9-Day RSI | 58.83 | |||||
14-Day RSI | 57.17 | |||||
6-1 Month Momentum % | -77.31 | |||||
12-1 Month Momentum % | -98.19 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 11.36 | |||||
Quick Ratio | 11.36 | |||||
Cash Ratio | 10.63 | |||||
Days Payable | 1064.63 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.4 | |||||
Shareholder Yield % | 2.27 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -58.52 | |||||
ROA % | -49.33 | |||||
ROIC % | -179.38 | |||||
ROC (Joel Greenblatt) % | -4511.74 | |||||
ROCE % | -56.62 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.38 | |||||
Price-to-Tangible-Book | 0.62 | |||||
EV-to-EBIT | 0.36 | |||||
EV-to-EBITDA | 0.36 | |||||
EV-to-Forward-EBITDA | -0.33 | |||||
EV-to-FCF | 0.32 | |||||
Price-to-Net-Current-Asset-Value | 0.63 | |||||
Price-to-Net-Cash | 0.69 | |||||
Earnings Yield (Greenblatt) % | 272.15 | |||||
FCF Yield % | -247.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Ultimovacs ASA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | |||
EPS (TTM) (kr) | -4.4 | ||
Beta | 0 | ||
Volatility % | 127.35 | ||
14-Day RSI | 57.17 | ||
14-Day ATR (kr) | 0.092384 | ||
20-Day SMA (kr) | 2.03075 | ||
12-1 Month Momentum % | -98.19 | ||
52-Week Range (kr) | 1.684 - 157 | ||
Shares Outstanding (Mil) | 34.41 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ultimovacs ASA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ultimovacs ASA Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Ultimovacs ASA Frequently Asked Questions
What is Ultimovacs ASA(OSTO:ULTIo)'s stock price today?
When is next earnings date of Ultimovacs ASA(OSTO:ULTIo)?
Does Ultimovacs ASA(OSTO:ULTIo) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |